Gapping up
In reaction to strong earnings/guidance: PEIX +27.4% (also plans to restart Madera, California plant ), JCP +22.1% (also disclosed the SEC concluded its investigation; not recommending action after investigation), BEAT +13.7%, DANG +10.9%, SB +10%, CIE +7.5%, NOAH +7.4%, SHLD +6.4%, VE +6.2%, BBY +6.1%, WDAY +5.7%, IQNT +5.5%, KW +5%, (light volume), ADSK+4.9%, SZYM +4.1%, ARCP +3.8%, LTXC +3.4% (light volume), RIG +3%, VRX +2.8%, WLL +2.2%, MYL +2.2%, RMTI +2.1% (light volume), BIDU +2.1%, HLT +2%, FWLT +2%, VALE +1.7% (light volume), BTI +1.2% (light volume).
M&A news: QIHU +2% (Qihoo 360 Tech. and Soufun may be takeover targets, Bloomberg real M&A column says).
Select China internet related names showing strength boosted by BIDU results: YOKU +2.8%, RENN +2%, SINA +0.7%, SOHU +0.7%.
Other news: BIOF +21.7% (PEIX sympathy), CTIC +8.3% (NICE publishes final guidance on PIXUVRI (pixantrone)), SVA +3.7% (announced that Phase III clinical trial results for its proprietary Enterovirus 71 vaccine have been published online), SYMX +3.5% (being attributed to speculation of GE investment in distributed power plant), CTRP +2.5% (Alibaba stake speculation), GRPN +2.3% (still checking), KNDI +1.9% (WSJ discusses that select China auto makers won approval from China to sell electric cars), GTAT +1.9% (still checking), BBRY +1.6% (Fairfax Financial disclosed 16.8% (~96.8 mln shares) active beneficial stake in amended 13D filing; Fairfax previously reported ~51.9 mln shares as of 12/31 , DO +1.5% (still checking), TTS +1.4% (following insider buying),DVA +1.2% (erkshire Hathaway disclosed buying more stock in an SEC filing out last night after the close ), WWAV +0.7% (postive MadMoney mention), TGT +0.5% (Barron's profiles positive view on Target).
Analyst comments: CSRE +8.2% (thinly traded; upgraded to Overweight from Equal-Weight at Morgan Stanley), SNP +3.2% ( added to Conviction Buy list at Goldman), FSLR +1.8% (First Solar upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $67 from $62), APD +1.3% (upgraded to Buy from Neutral at Citigroup; tgt raised to $133 from $119 ), PCAR +1% (initiated with an Overweight at Morgan Stanley), PTR +0.7% ( upgraded to Buy from Neutral at Goldman), ORCL +0.7% ( initiated with a Buy at B. Riley & Co.; tgt $48)
M&A news: QIHU +2% (Qihoo 360 Tech. and Soufun may be takeover targets, Bloomberg real M&A column says).
Select China internet related names showing strength boosted by BIDU results: YOKU +2.8%, RENN +2%, SINA +0.7%, SOHU +0.7%.
Other news: BIOF +21.7% (PEIX sympathy), CTIC +8.3% (NICE publishes final guidance on PIXUVRI (pixantrone)), SVA +3.7% (announced that Phase III clinical trial results for its proprietary Enterovirus 71 vaccine have been published online), SYMX +3.5% (being attributed to speculation of GE investment in distributed power plant), CTRP +2.5% (Alibaba stake speculation), GRPN +2.3% (still checking), KNDI +1.9% (WSJ discusses that select China auto makers won approval from China to sell electric cars), GTAT +1.9% (still checking), BBRY +1.6% (Fairfax Financial disclosed 16.8% (~96.8 mln shares) active beneficial stake in amended 13D filing; Fairfax previously reported ~51.9 mln shares as of 12/31 , DO +1.5% (still checking), TTS +1.4% (following insider buying),DVA +1.2% (erkshire Hathaway disclosed buying more stock in an SEC filing out last night after the close ), WWAV +0.7% (postive MadMoney mention), TGT +0.5% (Barron's profiles positive view on Target).
Analyst comments: CSRE +8.2% (thinly traded; upgraded to Overweight from Equal-Weight at Morgan Stanley), SNP +3.2% ( added to Conviction Buy list at Goldman), FSLR +1.8% (First Solar upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $67 from $62), APD +1.3% (upgraded to Buy from Neutral at Citigroup; tgt raised to $133 from $119 ), PCAR +1% (initiated with an Overweight at Morgan Stanley), PTR +0.7% ( upgraded to Buy from Neutral at Goldman), ORCL +0.7% ( initiated with a Buy at B. Riley & Co.; tgt $48)